Resolution at the Extraordinary General Meeting in BioInvent on March 23, 2021
With the resolution, a directed share issue of approximately SEK 962 million (approximately USD 116 million) will be completed according to plan. Lund, Sweden – March 23, 2021 – BioInvent International AB’s (publ) (”BioInvent”) (Nasdaq Stockholm: BINV) Extraordinary General Meeting (the “EGM”) today resolved to approve the Board of Directors’ resolution on a directed share issue of 16,260,601 new shares. The EGM resolved to approve the Board of Directors’ previous resolution on February 23, 2021 on a directed share issue of 16,260,601 shares, whereby the share capital increases by SEK